MONITORING CARDIAC OUTPUT AND VESSEL FLUID VOLUME

• US 20120123231A1
• Filed: 10/24/2011
• Published: 05/17/2012
• Est. Priority Date: 11/11/2010
• Status: Abandoned Application

• Current Assignee: Masimo Corporation
• Original Assignee: JP Morgan Chase Bank, N.A. (JP Morgan Chase & Co)
• Inventors: O'Reilly, Michael
• Application Number:
  US13/280,046
• Publication Number:
  US 20120123231A1
• Time in Patent Office: Days
• US Class Current: 600/340
• CPC Class Codes: A61B 5/0261 using optical means, e.g. infrared light
• CPC Class Codes: A61B 5/14551 for measuring blood gases

Abstract

The present disclosure describes embodiments of a patient monitoring system and methods that include the measure and display of hemoglobin statistics, cardiac output statistic and vessel volume statistics. In an embodiment, total hemoglobin trending, cardiac output, or vessel volume is displayed over a period of time. Statistics can include frequency domain analysis, differences between measurement sites, or further calculations based on concentrations and volume of fluids added to a patient which may be unique for each patient monitored. The total trending and/or statistics can further be used to help control the treatment of a patient, such as being used to control IV administration.

Claims

1. A patient monitoring system comprising:

at least two noninvasive sensors for emitting energy into at least two patient measurement sites and detecting the energy attenuated by the patient measurement sites;

a processing board comprising;

an instrument manager including a memory buffer; and

wherein the instrument manager is adapted to determine an indication of cardiac output using differences in the attenuated energy detected by the at least two sensors at the at least two measurement sites; and

a display adapted to output at least one indication of cardiac output.

2. The patient monitoring system of claim 1 wherein a first of the at least two measurement sites is on or near a patient'"'"'s head.

3. The patient monitoring system of claim 2 wherein a second of the at least two measurement sites is on a patient'"'"'s extremity.

4. The patient monitoring system of claim 3 wherein the second of the at least two measurement sites is on a patient'"'"'s finger.

5. The patient monitoring system of claim 4 wherein the first of the at least two measurements sites is on a patient'"'"'s ear.

6. The patient monitoring system of claim 1 wherein the difference is a difference in the recovery rate of the blood oxygenation saturation after a desaturation event.

7. The patient monitoring system of claim 6 wherein the difference is a signature in the recovery of the blood oxygenation.

8. The patient monitoring system of claim 1 wherein the difference is a time to reach a certain percentage recovery of the blood oxygenation.

9. The patient monitoring system of claim 1 further comprising:

an administration unit adapted to administer treatment to a patient and in communication with the processing board, wherein the treatment is administered based at least in part on the cardiac output.

10. The patient monitoring system of claim 9 wherein the treatment includes administration of at least one from the following:

a drug;

blood;

plasma;

nutrition;

or

an IV fluid.

11. A patient monitor device comprising:

a processing device capable of accepting signals indicative of optical energy attenuated by patient tissue detected from a noninvasive, optical sensor and further capable of interpreting the signals as a measurement of hemoglobin and calculating fluid volume measurements based at least in part on the measurement of hemoglobin;

a memory for storing a plurality of hemoglobin measurements interpreted by the processing device; and

a display for displaying the fluid volume measurements.

12. The patient monitor device of claim 11 wherein the display includes a graph of a plurality of fluid volume versus time.

13. The patient monitor device of claim 11 further comprising a mathematical module adapted to analyze the plurality of hemoglobin measurements to determine the fluid volume for display by the display.

14. The patient monitor device of claim 13 wherein the mathematical module comprises an algorithm based on the concentration of hemoglobin before a bolus of fluid is introduced into a patient'"'"'s vessels, an amount of the bolus of fluid introduced into a patient'"'"'s vessels, and the concentration of hemoglobin after the bolus of fluid is introduced into a patient'"'"'s vessels.

15. The patient monitor device of claim 14 wherein the mathematical module further comprises an approximation based on experimental data.

16. A method for monitoring patient cardiac output levels, the method comprising:

emitting energy into at least two patient measurement sites for attenuation by the at least two measurement sites;

detecting attenuated energy from the at least two measurement sites;

determining a plurality of indications of differences of blood oxygenation between the two measurements sites from the detected attenuated energy over a period of time;

calculating an indication of cardiac output based on the differences of blood oxygenation; and

displaying the indications of cardiac output.

17. The method for monitoring cardiac output levels of claim 16 further comprising the step of storing at least some of the plurality of indications of the differences in blood oxygenation in a buffer.

18. The method for monitoring cardiac output levels of claim 16 further comprising the steps of:

calculating a frequency analysis of the plurality of indications of the differences in blood oxygenation; and

displaying said frequency analysis.

19. The method for monitoring patient cardiac output levels of claim 16 wherein the differences in blood oxygenation represent differences in the recovery rates of blood oxygenation between the measurement sites.

20. A method for treating a patient based on determined vessel volume levels, the method comprising:

emitting energy into a patient measurement site for attenuation by the measurement site;

detecting attenuated energy from the measurement site;

determining a plurality of indications of total hemoglobin from the detected attenuated energy over a period of time;

determining a measure of vessel volume based on the indications of total hemoglobin; and

electronically determining a treatment based at least in part on the measure of vessel volume; and

administering the treatment.

21. The method for treating a patient of claim 20 wherein the step of determining a treatment includes at least one of a rate or amount of an IV treatment.